Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Little

Showing results (1-10 of 130) with videos related to

Pageof 13
Sort By:
Arthritis Research & Therapy|March 5, 2011
In vivo approaches to investigate ANCA-associated vasculitis: lessons and limitationsPeter Heeringa, Mark A Little
Current Opinion in Rheumatology|November 22, 2013
Renal transplantation in antineutrophil cytoplasmic antibody-associated vasculitisSarah Moran, Mark A Little
Journal of Nephrology|December 16, 2004
Rapidly progressive glomerulonephritis: current and evolving treatment strategiesMark A Little, Charles D Pusey
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 5, 2002
A longitudinal study of the repeated use of alteplase as therapy for tunneled hemodialysis catheter dysfunctionMark A Little, J Joseph Walshe
Current Opinion in Rheumatology|November 18, 2011
Animal models of antineutrophil cytoplasm antibody-associated vasculitisAlan D Salama, Mark A Little
Nephrology (Carlton, Vic.)|August 20, 2005
Glomerulonephritis due to antineutrophil cytoplasm antibody-associated vasculitis: an update on approaches to managementMark A Little, Charles D Pusey
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 23, 2004
Outcome in glomerulonephritis due to systemic small vessel vasculitis: effect of functional status and non-vasculitic co-morbidityMark A Little, Latiff Nazar, Ken Farrington
Rheumatology (Oxford, England)|April 30, 2020
Pathogenesis of ANCA-associated vasculitis: an emerging role for immunometabolismEmma Leacy, Gareth Brady, Mark A Little
Renal Failure|November 6, 2004
Waldenstrom's macroglobulinemia presenting as Goodpasture's syndromeSonia Gandhi, Mark A Little, Ken Farrington
Biochemical Pharmacology|February 1, 2020
Targeting of the cGAS-STING system by DNA virusesThomas Phelan, Mark A Little, Gareth Brady
Pageof 13

Showing results (1-10 of 130) with videos related to

Sort By:
Pageof 13
Arthritis Research & Therapy|March 5, 2011
In vivo approaches to investigate ANCA-associated vasculitis: lessons and limitationsPeter Heeringa, Mark A Little
Current Opinion in Rheumatology|November 22, 2013
Renal transplantation in antineutrophil cytoplasmic antibody-associated vasculitisSarah Moran, Mark A Little
Journal of Nephrology|December 16, 2004
Rapidly progressive glomerulonephritis: current and evolving treatment strategiesMark A Little, Charles D Pusey
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 5, 2002
A longitudinal study of the repeated use of alteplase as therapy for tunneled hemodialysis catheter dysfunctionMark A Little, J Joseph Walshe
Current Opinion in Rheumatology|November 18, 2011
Animal models of antineutrophil cytoplasm antibody-associated vasculitisAlan D Salama, Mark A Little
Nephrology (Carlton, Vic.)|August 20, 2005
Glomerulonephritis due to antineutrophil cytoplasm antibody-associated vasculitis: an update on approaches to managementMark A Little, Charles D Pusey
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 23, 2004
Outcome in glomerulonephritis due to systemic small vessel vasculitis: effect of functional status and non-vasculitic co-morbidityMark A Little, Latiff Nazar, Ken Farrington
Rheumatology (Oxford, England)|April 30, 2020
Pathogenesis of ANCA-associated vasculitis: an emerging role for immunometabolismEmma Leacy, Gareth Brady, Mark A Little
Renal Failure|November 6, 2004
Waldenstrom's macroglobulinemia presenting as Goodpasture's syndromeSonia Gandhi, Mark A Little, Ken Farrington
Biochemical Pharmacology|February 1, 2020
Targeting of the cGAS-STING system by DNA virusesThomas Phelan, Mark A Little, Gareth Brady
Pageof 13